Key Applications and Practices of Luciferase Reporter Gene Cell Lines in High-Throughput Drug Screening

Basic Principles and Selection Criteria of Reporter Gene Cell Lines

Reporter gene cell lines refer to cell lines in which a reporter gene (such as luciferase, green fluorescent protein, beta-galactosidase, etc.) is stably integrated into the genome of target cells through genetic engineering, so that its expression product can be detected conveniently and sensitively, thereby indirectly reflecting the activation or inhibition status of intracellular signaling pathways. In drug development, Firefly Luciferase and Renilla Luciferase are the two most common types of reporter genes. The bioluminescent signal intensity generated by their catalytic substrates is positively correlated with the expression level of the reporter gene, with low background noise and a wide dynamic range. Researchers usually choose a single-reporter or dual-reporter system according to the experimental purpose: a single-reporter system is suitable for simple promoter activity analysis; a dual-reporter system introduces an internal reference gene to eliminate bias caused by variables such as cell number and transfection efficiency.

Key Technical Steps of Stable Transfection and Monoclonal Screening

Constructing a cell line stably expressing a reporter gene usually involves four stages: vector design, transfection, screening, and identification. The vector generally contains the regulatory sequence of the target gene (such as a transcription factor binding site or full-length promoter) and the open reading frame of the reporter gene, and carries an antibiotic resistance gene (such as puromycin, neomycin, etc.). Transfection methods can include liposome-based methods, electroporation, or virus-mediated methods. Among them, lentiviral vectors are widely used in difficult-to-transfect cells (such as primary cells and suspension cells) because they can integrate into the host genome and achieve long-term stable expression. After transfection, monoclonal cells need to be obtained by limiting dilution or flow sorting, then expanded, cryopreserved, and verified batch by batch: generally, the basal signal level of the reporter gene is required to be within a preset threshold, the induction fold (such as the response intensity after agonist stimulation) is stable within an acceptable range, and there is no obvious signal drift after more than 20 consecutive passages.

Application Advantages and Precautions in High-Throughput Screening Scenarios

One of the most mature applications of reporter gene cell lines is high-throughput drug screening based on 96-well or 384-well plates. Researchers add test compounds to cells that have been pre-plated and cultured to logarithmic phase, incubate for a certain period, then add luciferase substrate, and read the luminescence value using a microplate reader or imaging system. Compared with traditional endpoint methods (such as Western Blot), reporter gene detection can greatly shorten operation time and improve throughput, and because the signal comes directly from living cells, it can reflect the transient effect of compounds on signaling pathways in real time. At present, this technology has been widely used in GPCR agonist/antagonist screening, discovery of nuclear receptor regulatory factors, and toxicology testing (such as evaluation of CYP enzyme induction activity). It should be noted that the compound's own fluorescence, interference with the substrate, or cytotoxicity may lead to false positive/false negative results. Therefore, before formal screening, sufficient negative controls, positive controls, and parallel cytotoxicity testing should be set up.

Support of Quality Control and Data Standardization for Result Reliability

To ensure comparability of data between different batches and different laboratories, the use of reporter gene cell lines must be accompanied by strict quality control procedures. For example, it is necessary to regularly test cell lines for mycoplasma contamination, reporter gene copy number, chromosomal stability, and response kinetic parameters; during experimental operations, the passage number after cell recovery, plating density, compound treatment time, and substrate reaction time should be standardized; during data analysis, it is recommended to use relative response ratios (such as agonist EC50 values and antagonist IC50 values) rather than absolute luminescence values, supplemented by internal reference correction. In addition, CRISPR-Cas9 technology that has emerged in recent years has shown unique advantages in the construction of reporter gene cell lines - it can precisely knock the reporter gene into the endogenous gene locus, avoiding expression heterogeneity caused by position effects, thereby further improving the reliability of screening data.